Neuroscience & Human Metabolism theme:

The Neuroscience and Human Metabolism theme excels in several related basic, translational and clinical areas and applies state-of-the art approaches in the study of normal processes and disease mechanisms.  There is basic research into neuroanatomy, cell physiology and pathology, the causes and management of heart disease and other metabolic disorders, development of new stem cell and other therapies for treatment of human disorders in the laboratory, and our research culminates in clinical trials and treatments in neurological and cardiovascular disease. Our work is based on multidisciplinary approaches to discover and treat the causes of disease and includes a wide range of technological approaches such as single cell and systems physiology, nanoscale devices and nanoparticles, confocal and electron microscopy, functional imaging and genetic studies.

In basic neuroscience, we conduct research into the functioning of the auditory system at the organ, cellular and molecular level, the physiology of retinal neurones, and plasticity in cortical processing in the somatosensory system. In human metabolism we investigate cellular mechanisms of atherogenesis, and the role of trace elements and antioxidants in disease.

In potentially translational neuroscience, we are performing research into stem cell therapy to promote neural regeneration and to treat diseases of the basal ganglia such as Parkinson’s disease.  We are also investigating possible regenerative/stem cell approaches to prevention of hearing loss.

ISTM_Harpal_at_cabinet_200x233  In  clinical neuroscience and human metabolism we are researching into multiple sclerosis (MS) and the range of neuropsychological deficits following stroke, including clinical trials in the treatment of both. We study dietary management of coronary risk, clinical management of dyslipidaemia and insulin resistance. We also research into polymorphic genes and how they interact with environmental factors such as ultraviolet radiation to influence susceptibility and outcome in MS, basal cell carcinoma and prostate cancer.

Associated with the theme, are other members of the institute that interact to enhance the cross-talk between different thematic research groups.  These areas include regenerative medicine in spinal cord repair, the neural control of breathing, and nanomagnetic technology in cell and tissue engineering and tumour targeting, 

NHM Theme Leader: Dr David Furness
NHM Clinical co-lead: Prof Clive Hawkins

For postgraduate research opportunities please go to the Prospective Student page.

  

ISTM Members in this theme

Research Seminars

News features

Keele_ageing_symposium_1_90x90   Research into Ageing Symposium Posted on 03 February 2012 More than 60 members of staff from various faculties attended the first Bridging the Gaps supported workshop on Ageing at the Sustainability Hub.   Daily Telegraph features Keele's stem cell research Posted on 04 January 2012 Research by Dr David Furness, into stem cells that could help combat hearing loss associated with old age, has been featured in the Daily Telegraph. Prof Gordon Ferns 90 x 90   A fire that Burns Within - Prof Gordon Ferns' Inaugural Lecture Posted on 10 March 2011 Professor Gordon Ferns gave the sixth lecture in the University's programme of Inaugural Lectures for 2010/11. The title of the lecture was "A fire that burns within: the impact of free radicals in health and disease". Parkinsons_donation_Dec2010_90x90   Donations towards Parkinson's Disease research Posted on 23 December 2010 Keele's Parkinson's disease research team has accepted donations totalling £20,000 towards supporting a project which aims to identify protein signals that can be used to produce dopamine nerves, which are lost in Parkinson's disease, from stem cells. Christine_Roffe_90x90   Stroke in Stoke... Prof Christine Roffe's Inaugural Lecture Posted on 13 October 2010 Professor Christine Roffe gave the opening lecture in the University's programme of Inaugural Lectures for 2010/11 “Stroke in Stoke and beyond”, on Tuesday, 5 October, 2010.